These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16884152)

  • 21. American Chemical Society - 229th National Meeting: bench to pilot plant.
    Rotella DP
    IDrugs; 2005 May; 8(5):390-1. PubMed ID: 15883918
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
    Soto FJ; Hanania NA
    Curr Opin Pulm Med; 2005 Mar; 11(2):129-34. PubMed ID: 15699784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease.
    Barnette MS; Underwood DC
    Curr Opin Pulm Med; 2000 Mar; 6(2):164-9. PubMed ID: 10741778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The next generation of PDE4 inhibitors.
    Huang Z; Ducharme Y; Macdonald D; Robichaud A
    Curr Opin Chem Biol; 2001 Aug; 5(4):432-8. PubMed ID: 11470607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Grootendorst DC; Rabe KF
    Curr Opin Allergy Clin Immunol; 2002 Feb; 2(1):61-7. PubMed ID: 11964752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
    Doggrell SA
    Expert Opin Pharmacother; 2006 Mar; 7(4):485-8. PubMed ID: 16503820
    [No Abstract]   [Full Text] [Related]  

  • 27. Are phosphodiesterase 4 inhibitors just more theophylline?
    Boswell-Smith V; Cazzola M; Page CP
    J Allergy Clin Immunol; 2006 Jun; 117(6):1237-43. PubMed ID: 16750981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents.
    Doherty AM
    Curr Opin Chem Biol; 1999 Aug; 3(4):466-73. PubMed ID: 10419856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilomilast.
    Schachter EN
    Drugs Today (Barc); 2006 Apr; 42(4):237-47. PubMed ID: 16703120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
    Buckley GM; Cooper N; Dyke HJ; Galleway FP; Gowers L; Haughan AF; Kendall HJ; Lowe C; Maxey R; Montana JG; Naylor R; Oxford J; Peake JC; Picken CL; Runcie KA; Sabin V; Sharpe A; Warneck JB
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1613-5. PubMed ID: 12039574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
    Giembycz MA
    Br J Clin Pharmacol; 2006 Aug; 62(2):138-52. PubMed ID: 16842388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
    Gamble E; Grootendorst DC; Brightling CE; Troy S; Qiu Y; Zhu J; Parker D; Matin D; Majumdar S; Vignola AM; Kroegel C; Morell F; Hansel TT; Rennard SI; Compton C; Amit O; Tat T; Edelson J; Pavord ID; Rabe KF; Barnes NC; Jeffery PK
    Am J Respir Crit Care Med; 2003 Oct; 168(8):976-82. PubMed ID: 12816740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease.
    Martina SD; Ismail MS; Vesta KS
    Ann Pharmacother; 2006 Oct; 40(10):1822-8. PubMed ID: 16985092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.
    Spina D
    Drugs; 2003; 63(23):2575-94. PubMed ID: 14636078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase inhibitors.
    Boswell-Smith V; Spina D; Page CP
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDE4 inhibitors in COPD--a more selective approach to treatment.
    Vignola AM
    Respir Med; 2004 Jun; 98(6):495-503. PubMed ID: 15191033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges.
    Renau TE
    Curr Opin Investig Drugs; 2004 Jan; 5(1):34-9. PubMed ID: 14983971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation.
    Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1585-99. PubMed ID: 17922623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.
    Shepherd MC
    Pulm Pharmacol Ther; 2006; 19(1):24-31. PubMed ID: 16046159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.